FDA issued a Warning Letter to Sewaren Innovative Pharmaceutical Packaging dba SIPP on 5/22/2017 as a result of this inspection.
483 Sewaren Innovative Pharmaceutical Packaging dba SIPP Jun 2016

483 Sewaren Innovative Pharmaceutical Packaging dba SIPP Jun 2016

Zakaria Ganiyu FDA, Melissa Roy FDA, Nancy Scheraga FDA$119.00 - Available Now

FDA investigators audited the Sewaren Innovative Pharmaceutical Packaging dba SIPP - Avenel, NJ, United States facility and issued 3 inspectional observations (via FDA 483) on 28 Jun 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 28 Jun 2016
  • Location: Avenel, United States
  • FEI: 3012292690
Add To Cart